Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 4/20 | 0.41 |
| ▸ | BRD4 | O60885 | 7/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.32 |
| ▸ | FPR3 | P25089 | 2/20 | 0.31 |
| ▸ | FPR2 | P25090 | 2/20 | 0.31 |
| ▸ | ATRIP | Q8WXE1 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | TTK | P33981 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30797892 | 0.88 | ATR (0.42) | ATRBRD4 | |
| SCHEMBL30797897 | 0.87 | ATR (0.46) | ATRBRD4ATRIPADORA3ADORA2A | |
| SCHEMBL30797724 | 0.84 | ATR (0.43) | ATRBRD4SYKFPR3FPR2 | |
| SCHEMBL30797730 | 0.79 | ATR (0.44) | ATRBRD4FPR3FPR2ATRIP | |
| SCHEMBL30797700 | 0.79 | ATR (0.47) | ATRBRD4FPR3FPR2ATRIP | |
| SCHEMBL30869078 | 0.79 | ATR (0.45) | ATRBRD4FPR3FPR2ADORA3 | |
| SCHEMBL30797851 | 0.78 | ATR (0.43) | ATRBRD4FPR3FPR2ATRIP | |
| SCHEMBL30869074 | 0.78 | ATR (0.43) | ATRBRD4FPR3FPR2ATRIP | |
| SCHEMBL30797685 | 0.77 | ATR (0.46) | ATRBRD4 | |
| SCHEMBL27377168 | 0.77 | ATR (0.41) | ATRBRD4FPR3FPR2ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584266-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |